| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/28/2013 | US20130053243 Plants having increased tolerance to herbicides |
| 02/28/2013 | US20130052681 Process for the selection of PHB-producing methanotrophic cultures |
| 02/28/2013 | US20130052679 L-threonine analysis method and l-threonine dehydrogenase |
| 02/28/2013 | US20130052676 Composition and Method for Assessing Regulation of Mast Cells |
| 02/28/2013 | US20130052674 Detecting the decomposition of enzymes in a test element by means of controlled release of a protected analyte |
| 02/28/2013 | US20130052673 Use of enzyme emulsion thickness to affect calibration code factors in test strip manufacturing |
| 02/28/2013 | US20130052672 Kit for measuring the thrombin generation in a sample of a sample of a patient's blood or plasma |
| 02/28/2013 | US20130052654 Amyloid Precursor Protein E2 Domain and Uses Thereof |
| 02/28/2013 | US20130052652 Method for generating a double stranded nucleic acid with a single stranded overhang |
| 02/28/2013 | US20130052651 Methods for sequencing polynucleotides |
| 02/28/2013 | US20130052647 Methods for fractionating and processing microparticles from biological samples and using them for biomarker discovery |
| 02/28/2013 | US20130052646 Positive and negative selectable markers for use in thermophilic organisms |
| 02/28/2013 | US20130052644 Predictive Markers Useful in the Treatment of Fragile X Syndrome (FXS) |
| 02/28/2013 | US20130052643 Method for generating nuclear reprogrammed cell, and use thereof |
| 02/28/2013 | US20130052642 Method for the identification and purification of human naturally occurring regulatory t cells (ntregs) |
| 02/28/2013 | US20130052641 Detection of streptococcus pneumoniae through magneto-amperometric genosensors using lyta gene-specific primers and probes |
| 02/28/2013 | US20130052640 Clostridium difficile dehydrogenase and toxin as a biomarker for monitoring infection in patients with clostridium difficile disease and differentiating carrier state from active disease |
| 02/28/2013 | US20130052639 Method of analyzing xpg endonuclease activity |
| 02/28/2013 | US20130052635 Method For Detecting Lipogenic Adenovirus |
| 02/28/2013 | US20130052634 Hcv genotype 4 replicons |
| 02/28/2013 | US20130052633 Hcv genotype 3 replicons |
| 02/28/2013 | US20130052303 Method for Improving Flavor Production in a Fermented Food Product |
| 02/28/2013 | US20130052206 Prognostic Marker For Cryoglobulinemic Vasculitis And B Cell Malignancies In HCV Infected Patients |
| 02/28/2013 | US20130052198 Anti-inflammatory factors |
| 02/28/2013 | US20130052186 Plasma Carboxypeptidase B as a Predictor for Disease Severity and Response |
| 02/28/2013 | US20130052172 Methods for diagnosing and treating cardiac defects |
| 02/28/2013 | US20130052160 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject |
| 02/28/2013 | DE112005001530B4 Verfahren zur Spektralidentifikation von Mikroorganismen Method for Spektralidentifikation of microorganisms |
| 02/28/2013 | DE102012203964B3 Determining concentration of specific nucleic acids in sample, comprises providing first probe comprising first and second oligonucleotides complementary to each other, and contacting first probe and second oligonucleotide with sample |
| 02/28/2013 | DE102006021722B4 Oligonukleotidsonden, Peptide, Verfahren und Kits zur Anreicherung, Immobilisierung, zum Nachweis oder zur Detektion von Erwinia amylovora Oligonucleotide probes, peptides, methods and kits for the enrichment, immobilization, detection, or for detection of Erwinia amylovora |
| 02/28/2013 | CA2846197A1 Novel kif5b-ret fusion molecules and uses thereof |
| 02/28/2013 | CA2846015A1 Conditionally replicating adenovirus |
| 02/28/2013 | CA2845568A1 Gene signatures for lung cancer prognosis and therapy selection |
| 02/28/2013 | CA2844913A1 Integrated method for high-throughput identification of novel pesticidal compositions and uses therefor |
| 02/28/2013 | CA2844779A1 Neurogenic and gliogenic factors and assays therefor |
| 02/28/2013 | CA2843756A1 Renal cell carcinoma biomarkers and uses thereof |
| 02/27/2013 | EP2562544A1 kits for use in the differentiation of IBD and IBS and further distinction between disease types of IBD |
| 02/27/2013 | EP2562536A1 Analyte detection method and analyte detection integrated circuit |
| 02/27/2013 | EP2562533A1 Membrane potential change detection device and membrane potential change detection method |
| 02/27/2013 | EP2562268A1 Noninvasive diagnosis of fetal aneuploidy by sequencing |
| 02/27/2013 | EP2562267A2 Method and kit for identifying Phalaenopsis varieties |
| 02/27/2013 | EP2562266A1 Predetermined site luminescence measuring method, predetermined site luminescence measuring apparatus, expression amount measuring method, and measuring apparatus |
| 02/27/2013 | EP2562265A1 Susceptibility to selective CDK9 inhibitors |
| 02/27/2013 | EP2562264A1 Method for assaying histone methylation enzyme activity |
| 02/27/2013 | EP2562255A1 Nucleic acid base analog with quenching characteristics and fluorescence and application thereof |
| 02/27/2013 | EP2562254A1 Novel dna methylation analysis method |
| 02/27/2013 | EP2562251A1 Cholesterol oxidase |
| 02/27/2013 | EP2562250A1 Glucose oxidase |
| 02/27/2013 | EP2562247A2 Pcr device including two heating blocks |
| 02/27/2013 | EP2562246A1 Cell observation device and cell observation method |
| 02/27/2013 | EP2562245A1 Cell observation device and cell observation method |
| 02/27/2013 | EP2562169A1 Tetrazolium compound for detecting microorganisms, reagent for detecting microorganisms and method for detecting microorganisms |
| 02/27/2013 | EP2561887A2 Cancer therapy sensitizer |
| 02/27/2013 | EP2561368A2 Compositions and methods for prediction of drug sensitivity, resistance, and disease progression |
| 02/27/2013 | EP2561364A2 Method and apparatus for forming of an automated sampling device for the detection of salmonella enterica utilizing an electrochemical aptamer biosensor |
| 02/27/2013 | EP2561360A1 Isolating a target analyte from a body fluid |
| 02/27/2013 | EP2561357A1 Dna intercalator detection |
| 02/27/2013 | EP2561355A1 Method for diagnosing melanocytic proliferations |
| 02/27/2013 | EP2561353A1 Predictors of pharmacokinetic and pharmacodynamic disposition of carrier-mediated agents |
| 02/27/2013 | EP2561351A2 Novel biomarkers and targets for ovarian carcinoma |
| 02/27/2013 | EP2561105A1 Mutant strains of escherichia coli, a method of testing potential antibacterial agents using said strains as well as a testing kit |
| 02/27/2013 | EP2561104A2 Diagnosis of viral infections by detection of genomic and infectious viral dna by molecular combing |
| 02/27/2013 | EP2561103A1 Noninvasive detection of fetal genetic abnormality |
| 02/27/2013 | EP2561102A1 Irak-related interventions and diagnosis |
| 02/27/2013 | EP2561101A2 X-str multiplex system |
| 02/27/2013 | EP2561100A2 Systems and methods of selecting combinatorial coordinately dysregulated biomarker subnetworks |
| 02/27/2013 | EP2561099A1 Separating target analytes using alternating magnetic fields |
| 02/27/2013 | EP2561098A1 Tethered enzyme mediated nucleic acid detection |
| 02/27/2013 | EP2561097A2 Methylation profiling of dna samples |
| 02/27/2013 | EP2561096A2 Means and methods for determining risk of cardiovascular disease |
| 02/27/2013 | EP2561095A1 Two-color chromogenic in situ hybridization |
| 02/27/2013 | EP2561094A2 Compositions, methods and kits to detect herpes simplex virus nucleic acid |
| 02/27/2013 | EP2561093A1 Methods for predicting an antibody response to interferon therapy in multiple sclerosis patients |
| 02/27/2013 | EP2561092A1 Genetic signatures and gene chips associated with administration of electrically conducted radio frequency current to skin and methods and treatments relating thereto |
| 02/27/2013 | EP2561091A1 Complex mirna sets as novel biomarkers for an acute coronary syndrome |
| 02/27/2013 | EP2561090A1 Genetic factors associated with inhibitor development in hemophilia a |
| 02/27/2013 | EP2561089A2 Method of determining the metastatic potential of a tumor |
| 02/27/2013 | EP2561088A1 Compounds and uses thereof to induce an immunogenic cancer cell death in a subject |
| 02/27/2013 | EP2561087A2 Physiological methods for isolation of high purity cell populations |
| 02/27/2013 | EP2560995A1 Assay for identification of lrrk2 inhibitors |
| 02/27/2013 | EP2560985A1 Nucleic acid sequences of a fish virus and the use thereof |
| 02/27/2013 | EP2560983A1 Methods and compositions for the detection and identification of archaea based on the type ii chaperonin (thermosome) gene |
| 02/27/2013 | EP2093286B1 Multi-chain eukaryotic display vectors and uses thereof |
| 02/27/2013 | CN202754998U Hepatitis B virus multi-drug resistant gene mutation detection kit |
| 02/27/2013 | CN102947710A Hanging drop devices, systems and/or methods |
| 02/27/2013 | CN102947706A Compositions and methods for prediction of drug sensitivity, resistance, and disease progression |
| 02/27/2013 | CN102947468A Method for detection of colorectal tumor |
| 02/27/2013 | CN102947467A Assays and kits for serotyping pseudomonas aeruginosa and oligonucleotide sequences useful in such methods and kits |
| 02/27/2013 | CN102947466A Mononucleotide polymorphisms of the human chromosome 4 in the inositol polyphosphate 4-phosphatase type ii gene (inpp4b gene) for diagnosing or pre-diagnosing multiple sclerosis |
| 02/27/2013 | CN102947465A Methods for identifying drug resistant mycobacterium |
| 02/27/2013 | CN102947464A A method for identifying bacteria in a sample |
| 02/27/2013 | CN102947463A Fluorescent probe for plasma cell identification and isolation, and plasma cell identification or isolation method using the probe |
| 02/27/2013 | CN102947462A Diagnostic instrument and flow process |
| 02/27/2013 | CN102947449A Method for simultaneous achievement of bacteriolysis of acid-fast bacterium and separation of nucleic acid from the bacterium |
| 02/27/2013 | CN102947448A Composition for preventing evaporation of reaction solution during nucleic acid amplification reaction |
| 02/27/2013 | CN102947446A Prognostic method for pulmonary adenocarcinoma, pulmonary adenocarcinoma detection kit, and pharmaceutical composition for treating pulmonary adenocarcinoma |
| 02/27/2013 | CN102947339A Assay for identification of LRRK2 inhibitors |
| 02/27/2013 | CN102947266A Method of analysing a cell or other biological material containing a nucleic acid |
| 02/27/2013 | CN102947005A Method for determining one or more characterizing features of a macromolecule and an apparatus for carrying out said method |
| 02/27/2013 | CN102946714A Herbicide-tolerant plants |